Search for: "Fresenius Manufacturing, Inc."
Results 21 - 38
of 38
Sort by Relevance
|
Sort by Date
26 Jun 2014, 12:38 pm
Fresenius USA Manufacturing, Inc., 358 NLRB 138 (Sept. 19, 2012) – holding that while an employer’s investigation into a harassment complaint was entirely lawful, its discipline of a union member for writing a vulgar term was unlawful because the activity was “protected” by the NLRA. [read post]
2 Jun 2014, 7:48 am
Fresenius Kabi USA, LLC v. [read post]
7 May 2014, 6:45 am
Baxter International, Inc. v. [read post]
21 Apr 2014, 12:23 pm
Davita Healthcare Partners, Inc., 2014 U.S. [read post]
1 Apr 2013, 2:15 pm
Less than a year after Omontys was FDA-approved, however, all lots of this apparently unsafe drug were recalled by its manufacturer, Affymax Inc., as we reported in this article, "Kidney Dialysis Anemia Drug Recall: Omontys: Hypersensitivity / Allergic Reactions And Anaphylaxis; Serious Side Effects With Some Being Fatal". [read post]
31 Jan 2013, 2:33 pm
An Oklahoma woman has filed a wrongful death lawsuit against Fresenius Medical Care and Davita Inc. alleging that her mother died as a result of side effects caused by GranuFlo, a medication that is used in dialysis treatments. [read post]
5 Oct 2012, 10:16 am
The suit was served on Fresenius USA INC, and names the GranuFlo manufacturer and several of its subsidiaries. [read post]
5 Nov 2010, 1:38 pm
This was impermissible because a patentee can recover damages only from the government for patented "use or manufacture for the United States. [read post]
20 Aug 2010, 8:11 am
Fresenius Medical Care Holdings, Inc. v. [read post]
10 Feb 2010, 4:47 pm
Fresenius Kabi Oncology PLC (Patent Docs) Neutrokine-? [read post]
20 Feb 2009, 5:00 am
(Chicago Intellectual Property Law Blog) Center for American Progress report a mixed bag of recommendations to Obama Administration (Patent Docs) Manufacturing letter on patent reform to President Obama (Anticipate This!) [read post]
9 Feb 2009, 5:10 am
However, if such claims are based solely on allegations that the respective defendants violated the FDCA, then the claims are preempted.The case involves a group of seven health benefit plans accusing Amgen, Inc., DaVita, Inc. and Fresenius Medical Care Holdings, Inc. of unlawfully promoting the off-label use of two drugs, Epogen and Aranesp (collectively, “EPO”), between 2002 and 2007. [read post]
1 Nov 2008, 3:12 am
(IP Dragon) Amendments to the PRC patent law (IP Frontline) Ethiopia Ethiopia streamlines trade mark formalities (Afro-IP) Europe Blind readers seek guarantee of access under EU copyright law (Intellectual Property Watch) CFI dismisses Philip Morris' appeal against OHIM's persistent refusal to register the shape of its cigarette packet as a community trade mark (IPKat) CFI rules PAST PERFECT not descriptive for musical recordings: TIM The International Music Company AG,… [read post]
9 Jun 2008, 1:42 pm
The lunatics are running the insane asylum (via Employment Law 360): Fresenius Wins New Election In Union Spat: The National Labor Relations Board has ruled that an administrative law judge erred in overruling objections by Fresenius USA Manufacturing Inc. that... [read post]
6 Jun 2008, 6:49 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files opposition: Teva Pharma USA… [read post]
11 Apr 2008, 9:00 am
’ – 18 – 22 June, US/Alaska: (Public Knowledge), Center for IP 8th Annual IP Symposium – 28-30 May, Maryland US: (Public Knowledge), University of Maastricht: Conference on public health, innovation and intellectual property – 15 April, Maastricht (Netherlands): (IPR-Helpdesk), NLSIU Symposium: ‘Challenges to India’s patent regime’ – 12-13 April: (Spicy IP), Anti-counterfeiting and brand… [read post]
11 Apr 2008, 3:00 am
Nabi sold its PhosLo drug product to Fresenius USA Manufacturing, Inc. [read post]
